-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Acetylsalicylic Acid-[d3]
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/921943-73-9.gif)
| Category | Virus Protease |
| CAS | 921943-73-9 |
| Description | Acetylsalicylic Acid-[d3] is the labelled analogue of Acetylsalicylic Acid, which is a nonsteroidal anti-inflammatory drug (NSAID) used for the treatment of pains and inflammations. |
Product Information
| Synonyms | Acetylsalicylic Acid D3; Aspirin-d3; 2-Acetoxybenzoic Acid-d3; 2-(Acetyloxy)benzoic Acid-d3; 2-(Acetyl-2,2,2-d3-oxy)-benzoic Acid; Acetyl-d3-salicylic Acid; O-Acetylsalicylic Acid-d3; O-Acetoxybenzoic Acid-d3; Acylpyrin-d3 |
| IUPAC Name | 2-(2,2,2-trideuterioacetyl)oxybenzoic acid |
| Molecular Weight | 183.18 |
| Molecular Formula | C9H5D3O4 |
| Canonical SMILES | CC(=O)OC1=CC=CC=C1C(=O)O |
| InChI | InChI=1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12)/i1D3 |
| InChIKey | BSYNRYMUTXBXSQ-FIBGUPNXSA-N |
| Melting Point | 134-136 °C |
| Purity | ≥97%; ≥97% atom D |
| Density | 2.6±0.1 g/cm3 |
| Solubility | Soluble in Acetonitrile (Slightly), Chloroform (Slightly), DMSO (Slightly) |
| Appearance | White Solid |
| Storage | Store at -20°C under inert atmosphere |
| Complexity | 212 |
| Exact Mass | 539.00197477 |
| Index Of Refraction | 1.804 |
| In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and Metabolic profiles of drugs. |
| Target | COX; Autophagy; Mitophagy; Virus Protease |
| XLogP3-AA | 1.2 |
